News | February 03, 2014

Researcher Finds Significant Cardiac Treatment Imbalance Nationally

February 3, 2014 — Percutaneous coronary intervention (PCI) centers are unequal relative to population and heart attack prevalence across the United States, according to a study in the Journal of the American Heart Association. A multi-center team led by James Langabeer II, Ph.D., The University of Texas Health Science Center at Houston, conducted the study
 
Langabeer and co-lead author Timothy Henry, M.D., Minneapolis Heart Institute Foundation, Abbott Northwestern Hospital, found that people who live in urban areas have access to more PCI centers than necessary. Those who live in some rural areas are unable to access a PCI center within 60 minutes, the recommended time to receive treatment after the onset of heart attack symptoms.
 
Researchers examined the distribution of PCI centers in each state and compared that to population density and heart attack prevalence. The number of PCI centers has grown 21 percent nationwide in the last eight years, with 39 percent of all hospitals having interventional cardiology capabilities. While PCI centers continue to grow, heart attacks are decreasing. Langabeer’s discovery unveils an unequal geographic distribution of PCI capacity for treating heart attack patients.
 
Some western states, such as Nevada, had higher than median disease prevalence rates, yet have only an average number of PCI centers for its population. Locations in the south central and north central region, such as Alabama and Montana, had significantly higher relative PCI facilities compared to some of the states with even higher disease rates.
 
“There is a growing trend nationally for hospitals to all become PCI capable, for a variety of reasons. As long as the capacity is aligned with the need, this is positive. However, in this research, we found significant disparity geographically when we normalized capacity by population density” Langabeer said. “These imbalances are creating problems on a national scale.”
 
The study is called "Growth in Percutaneous Coronary Intervention Capacity Relative to Population and Disease Prevalence." Co-authors are from the American Heart Association, Boston University School of Medicine, Duke University Medical Center, The Christ Hospital Heart and Vascular Center and UT Southwestern Medical Center.
 
For more information: www.ahajournals.org

Related Content

News | Cardiovascular Clinical Studies

June 11, 2025 — Bayer and the Broad Institute have have extended their research collaboration of 10 years by an ...

Home June 11, 2025
Home
News | Cardiovascular Clinical Studies

May 27, 2025 — Despite scientific advances in cardiovascular care, people in living in rural areas and other communities ...

Home May 27, 2025
Home
News | Cardiovascular Clinical Studies

May 20, 2025 — Shockwave Medical, Inc., part of Johnson & Johnson MedTechhas announced the 30-day primary endpoint ...

Home May 21, 2025
Home
News | Cardiovascular Clinical Studies

Jan. 13, — A new cohort study among 103,642 adults found that current use of cigars was associated with increased risk ...

Home January 14, 2025
Home
News | Cardiovascular Clinical Studies

Nov. 22, 2024 — BridgeBio Pharma, Inc. recently announced that the U.S. Food and Drug Administration (FDA) approved ...

Home November 25, 2024
Home
News | Cardiovascular Clinical Studies

Nov. 18, 2024 — Silence Therapeutics presented end-of-treatment data from its Phase 2 ALPACAR-360 study of zerlasiran, a ...

Home November 18, 2024
Home
News | Cardiovascular Clinical Studies

Aug. 15, 2024 — According to a new study being presented at ACC Asia 2024 in Delhi, India, drinking over 400 mg of ...

Home August 14, 2024
Home
Videos | Cardiovascular Clinical Studies

As part of DAIC's continuing Thought Leadership Series, this month Editorial Director Melinda Taschetta-Millane sits ...

Home July 30, 2024
Home
News | Cardiovascular Clinical Studies

July 25, 2024 — BioCardia, Inc., a global leader in cellular and cell-derived therapeutics for the treatment of ...

Home July 25, 2024
Home
News | Cardiovascular Clinical Studies

July 18, 2024 — Elucid, a pioneering AI medical technology company providing physicians with imaging analysis software ...

Home July 18, 2024
Home
Subscribe Now